ICSFX
Price
$31.36
Change
+$0.15 (+0.48%)
Updated
Sep 4 closing price
Net Assets
12.85B
VIVIX
Price
$71.19
Change
-$0.23 (-0.32%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

ICSFX vs VIVIX

Header iconICSFX vs VIVIX Comparison
Open Charts ICSFX vs VIVIXBanner chart's image
Invesco Comstock R6
Price$31.36
Change+$0.15 (+0.48%)
VolumeN/A
Net Assets12.85B
Vanguard Value Index I
Price$71.19
Change-$0.23 (-0.32%)
VolumeN/A
Net Assets202.84B
ICSFX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ICSFX vs. VIVIX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICSFX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 203B vs. ICSFX (12.9B). VIVIX pays higher dividends than ICSFX: VIVIX (2.11) vs ICSFX (1.82). ICSFX was incepted earlier than VIVIX: ICSFX (13 years) vs VIVIX (27 years). ICSFX (0.45) is less costly to investors than VIVIX (0.04). ICSFX is a more actively managed with annual turnover of: 26.00 vs. VIVIX (9.00). ICSFX has a lower initial minimum investment than VIVIX: ICSFX (1000000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.74 vs. ICSFX (5.20). VIVIX return over 5 years is better than : 70.16 vs. ICSFX (62.69).
ICSFXVIVIXICSFX / VIVIX
Total Expense Ratio0.450.041,125%
Annual Report Gross Expense Ratio0.450.041,125%
Fund Existence13 years27 years-
Gain YTD10.5187.866134%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets12.9B203B6%
Annual Yield % from dividends1.822.1186%
Returns for 1 year5.207.7467%
Returns for 3 years19.0536.6152%
Returns for 5 years62.6970.1689%
Returns for 10 years55.92131.6142%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XRTX0.820.01
+1.85%
XORTX Therapeutics
CPT111.361.02
+0.92%
Camden Property Trust
TMCI7.17N/A
N/A
Treace Medical Concepts
AGIO36.01-0.12
-0.33%
Agios Pharmaceuticals
ZENV1.51-0.05
-3.21%
Zenvia